<DOC>
	<DOCNO>NCT01312831</DOCNO>
	<brief_summary>The purpose study compare efficacy safety profile new oral vitamin B12 formulation ( Eligen® B12 ) intramuscular B12 restore normal B12 ( cobalamin ) concentration subject low cobalamin level ( &lt; 350 pg/mL ) .</brief_summary>
	<brief_title>Efficacy Safety Study Oral Eligen® B12 Subjects With Low Serum Cobalamin</brief_title>
	<detailed_description />
	<mesh_term>Vitamin B 12 Deficiency</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<criteria>Vitamin B12 deficiency define serum cobalamin 350 pg/mL Age 60 older ; age 18 old gastrointestinal abnormality include limited gastrointestinal surgery ( e.g . gastrectomy , gastric bypass ) , ileal resection , gastric atrophy , Celiac disease , Crohn 's disease , prolong use ( &gt; 3 month ) proton pump inhibitor drug , restrict diet ( vegetarian vegan ) . General good health , indicate lack significant finding medical history , physical examination , clinical laboratory test ( chemistry , hematology urinalysis ) , vital sign , ECG normal kidney function determine estimate creatinine clearance compute Cockcroft Gault formula Current treatment health care provider treat vitamin B12 deficiency and/or symptom ; Daily use neutralize antacid ( e.g . Maalox® ) Inability ingest oral medication Clinically significant laboratory value screen Hypersensitivity allergic reaction vitamin B12 Participation clinical research study involve new chemical entity within 30 day first study dose Folate level reference range provide clinical laboratory . Renal insufficiency Vitamin B6 deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>cobalamin</keyword>
	<keyword>B12</keyword>
	<keyword>homocysteine</keyword>
	<keyword>MMA</keyword>
	<keyword>holotranscobalamin</keyword>
	<keyword>Eligen</keyword>
</DOC>